Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial

2026/02/10 by Jeremy A Hawkins, Jeffrey R Curtis, Jeffrey H. Curtis +14 · 3 citations
Medicine · #Abatacept #Clinical trial #Herpesvirus Infections and Treatments #Immunogenicity #Ocular Diseases and Behçet’s Syndrome #Randomized controlled trial #Reactogenicity #Rheumatoid Arthritis Research and Therapies #Rheumatoid arthritis #Vaccination

paper · doi:10.1016/j.ard.2026.01.002

published in Annals of the Rheumatic Diseases 85(5), 787-796 (BMJ)

openalex publication_date 2026/02/10 · openalex created_date 2026/02/11 · openalex updated_date 2026/08/05

Cited by

• Recombinant zoster vaccine in patients with inflammatory rheumatic diseases: efficacy, long-term protection and safety under immunosuppression. [europepmc]